Watermark Asset Management’s Novo Nordisk NVO Stock Holding History

Watermark Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$16K	Hold	690	–	–	0.01%	147
2018 Q3	$16K	Hold	690	–	–	0.01%	140
2018 Q2	$16K	Hold	690	–	–	0.01%	140
2018 Q1	$17K	Sell	690 -160	-19%	-$4.2K	0.01%	146
2017 Q4	$23K	Hold	850	–	–	0.01%	136
2017 Q3	$20K	Hold	850	–	–	0.01%	141
2017 Q2	$18K	Hold	850	–	–	0.01%	143
2017 Q1	$15K	Buy	+850	New	+$14.8K	0.01%	148

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Watermark Asset Management's NVO Position: Q4 2018 in Review

Watermark Asset Management held its Novo Nordisk (NVO) position steady in Q4 2018 at 690 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #147.

Watermark Asset Management first reported a position in NVO in Q1 2017 and has held it in 8 quarters since. The position peaked at $23K in Q4 2017. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

Watermark Asset Management held 690 shares of Novo Nordisk worth $16K as of Q4 2018.
Watermark Asset Management left its Novo Nordisk share count unchanged in Q4 2018.
Novo Nordisk made up 0.01% of Watermark Asset Management's portfolio in Q4 2018, its #147 holding.
Watermark Asset Management first reported a position in Novo Nordisk in Q1 2017 and has held it in 8 quarters since.
Watermark Asset Management's Novo Nordisk position peaked at $23K in Q4 2017.
550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on Watermark Asset Management's 13F filing for Q4 2018, filed 14 Jan 2019.